Bio Nano Consulting will be hosting ‘Nanotechnology in Drug Discovery & Development' Breakfast meeting at the British Consulate-General, 1 Sansome St # 850, San Francisco, CA 94104 - Tuesday 5th October, 2010 8 am -10:30 am
EVENT BACKGROUND
Nanotechnology has the ability to improve drug R&D by decreasing volumes of expensive reagents, increasing the information available about potential drugs and targets, facilitating high content screening, and enabling improved delivery through increased solubility or selective tissue targeting.
AGENDA
Registration & Breakfast
Welcome and Introductions
Marcie Newman, Vice Consul, Life Sciences, UK Trade & Investment
Dr. David Sarphie, Chief Executive Officer, Bio Nano Consulting
Clinical Opportunities and Nanotechnology
Prof. Patrick Maxwell, Head, Division of Medicine, University College London
Bionanotechnology and the Foundations of Nanomedicine
Prof. Tony Cass, Professor of Chemical Biology, Imperial College London
Nanotechnology and Assays for Drug/Target Binding
Prof. Gabriel Aeppli FRS, Director, London Centre for Nanotechnology
Networking and Coffee
To book your free place at this event, please email mike.fisher@bio-nano-consulting.com by the 27th September 2010